Mark T.A. Donoghue

12.9k citations

58 papers · 3.1k indexed · 2 hit papers · h-index 23

Cancer Research top 2%
- Cancer Genomics and Diagnostics 17
Plant Science top 2%
- Plant nutrient uptake and metabolism 9
- Plant Molecular Biology Research 8
Molecular Biology top 5%
Oncology top 5%
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 5
Genetics top 5%
Pulmonary and Respiratory Medicine
- Sarcoma Diagnosis and Treatment 7
- Lung Cancer Treatments and Mutations 5
Surgery
- Testicular diseases and treatments 5

Co-authors: Charles Spillane S. Duygu Selçuklu Robert A. Martienssen Barry S. Taylor Filipe Borges Frédéric Van Ex Rui Gardner Joseph P. Calarco
Cited by: Cancer Research Plant Science Molecular Biology
Partner nations: United States Ireland Canada

In The Last Decade

Mark T.A. Donoghue

54 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2018 Genome doubling shapes the evolution and prognosis of advanced cancers
2012 Reprogramming of DNA Methylation in Pollen Guides Epigenetic Inheritance via Small RNA

Peers

Countries citing papers authored by Mark T.A. Donoghue

Since Specialization

Citations

This map shows the geographic impact of Mark T.A. Donoghue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T.A. Donoghue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T.A. Donoghue more than expected).

Fields of papers citing papers by Mark T.A. Donoghue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T.A. Donoghue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T.A. Donoghue. The network helps show where Mark T.A. Donoghue may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark T.A. Donoghue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark T.A. Donoghue Line = papers co-authored together Mark T.A. Donoghue links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases James A. Wilcox,Mark Jeng,S Tischfield,Jane Sze Yin Sui,Dmitry Nemirovsky,Glenn Heller,Noura J. Choudhury,Jeff Ross,Charles M. Rudin,Gregory J. Riely,Mark G. Kris,Mark T.A. Donoghue,Adrienne Boire,Helena A. Yu	2025	0
2	Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors Andrew Lin,Vasilisa A. Rudneva,Adam Newton,Nazanin Majd,Rajiv Magge,Soma Sengupta,Bernard Goichot,Anna F. Piotrowski,Igor T. Gavrilovic,Odelia Cooper,Marc K. Rosenblum,Thomas Kaley,Ingo K. Mellinghoff,Robert J. Young,Mark T.A. Donoghue,Viviane Tabar,Eliza B. Geer	2025	5
3	Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy Charlotte S. Walmsley,Philip Jonsson,Michael L. Cheng,Sean M. McBride,Christopher Kaeser,H. Alberto Vargas,Vincent P. Laudone,Barry S. Taylor,Rajya Kappagantula,Priscilla Baez,Allison L. Richards,Anne Marie Noronha,D. S. Perera,Michael F. Berger,David B. Solit,Christine A. Iacobuzio–Donahue,Howard I. Scher,Mark T.A. Donoghue,Wassim Abida,Alison M. Schram	2024	7
4	Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas Evan Rosenbaum,Kenneth Seier,Martina Bradić,Ciara M. Kelly,Sujana Movva,Benjamin A. Nacev,Mrinal M. Gounder,Mary Louise Keohan,Viswatej Avutu,Ping Chi,Katherine A. Thornton,Jason E. Chan,Mark A. Dickson,Mark T.A. Donoghue,William D. Tap,Li‐Xuan Qin,Sandra P. D’Angelo	2023	6
5	AKT mutant allele-specific activation dictates pharmacologic sensitivities Tripti Shrestha Bhattarai,Tambudzai Shamu,Alexander N. Gorelick,Matthew T. Chang,Debyani Chakravarty,Elena I. Gavrila,Mark T.A. Donoghue,JianJong Gao,Swati Patel,Sizhi Paul Gao,Margaret H. Reynolds,Sarah Phillips,Tara E. Soumerai,Wassim Abida,David M. Hyman,Alison M. Schram,David B. Solit,Lillian M. Smyth,Barry S. Taylor	2022	26
6	HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome Evan Rosenbaum,Kenneth Seier,Chaitanya Bandlamudi,Mark A. Dickson,Mrinal M. Gounder,Mary Lou Keohan,Ping Chi,Ciara M. Kelly,Sujana Movva,Benjamin A. Nacev,Noemi Simeone,Mark T.A. Donoghue,Emily K. Slotkin,Li‐Xuan Qin,Cristina R. Antonescu,William D. Tap,Sandra P. D’Angelo	2020	12
7	Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing Martee L. Hensley,Shweta S. Chavan,David B. Solit,Rajmohan Murali,Robert A. Soslow,Sarah Chiang,Achim A. Jungbluth,Chaitanya Bandlamudi,Preethi Srinivasan,William D. Tap,Evan Rosenbaum,Barry S. Taylor,Mark T.A. Donoghue,David M. Hyman	2020	67
8	Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma Caitlin A. McIntyre,Sharon Lawrence,Allison L. Richards,Joanne F. Chou,Winston Wong,Marinela Capanu,Michael F. Berger,Mark T.A. Donoghue,Kenneth H. Yu,Anna M. Varghese,David P. Kelsen,Wungki Park,Vinod P. Balachandran,T. Peter Kingham,Michael I. D’Angelica,Jeffrey A. Drebin,William R. Jarnagin,Christine A. Iacobuzio–Donahue,Peter J. Allen,Eileen M. O’Reilly	2020	49
9	A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers Paul K. Paik,Rachel K. Kim,Linda S. Ahn,Andrew J. Plodkowski,Ai Ni,Mark T.A. Donoghue,Philip Jonsson,Miguel A. Villalona‐Calero,Kenneth Ng,Daniel C. McFarland,John J. Fiore,Afsheen N. Iqbal,Juliana Eng,Mark G. Kris,Charles M. Rudin	2020	10
10	Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor Andrew Lin,Mark T.A. Donoghue,Sharon L. Wardlaw,Jonathan T. Yang,Lisa Bodei,Viviane Tabar,Eliza B. Geer	2020	15
11	A07 The Genomic Landscape of SMARCA4 Alterations and Association with Patient Outcomes in Lung Cancer Adam J. Schoenfeld,Joseph Montecalvo,Azadeh Namakydoust,Jessica A. Lavery,Chai Bandlamudi,Hira Rizvi,Steven M. Paul,Maria E. Arcila,Jason C. Chang,Jennifer L. Sauter,Amanda Beras,Marc Ladanyi,Barry S. Taylor,Mark T.A. Donoghue,Glenn Heller,Matthew D. Hellmann,Natasha Rekhtman,Gregory J. Riely	2020	1
12	Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas A.J. Schoenfeld,H. Rizvi,Chai Bandlamudi,Jennifer L. Sauter,William D. Travis,Natasha Rekhtman,Andrew J. Plodkowski,Rocío Pérez-Johnston,Peter Sawan,Amanda Beras,Jacklynn V. Egger,M. Ladanyi,Kathryn C. Arbour,Charles M. Rudin,G.J. Riely,Barry S. Taylor,Mark T.A. Donoghue,Matthew D. Hellmann	2020	219
13	Transgenerational effects of inter-ploidy cross direction on reproduction and F2 seed development of Arabidopsis thaliana F1 hybrid triploids Dorota Duszynska,Bjarni J. Vilhjálmsson,Rosa Castillo Bravo,Sandesh H Swamidatta,Thomas Juenger,Mark T.A. Donoghue,Aurélie Comte,Magnus Nordborg,Timothy F. Sharbel,Galina Brychkova,Peter C. McKeown,Charles Spillane	2019	6
14	Uncovering Differentially Methylated Regions (DMRs) in a Salt-Tolerant Rice Variety under Stress: One Step towards New Regulatory Regions for Enhanced Salt Tolerance Liliana J. Ferreira,Mark T.A. Donoghue,Pedro M. Barros,Nelson J. M. Saibo,Ana Paula Santos,M. Margarida Oliveira	2019	19
15	Genome doubling shapes the evolution and prognosis of advanced cancersbreakdown → Craig M. Bielski,Ahmet Zehir,Alexander Penson,Mark T.A. Donoghue,Walid K. Chatila,Joshua Armenia,Matthew T. Chang,Alison M. Schram,Philip Jonsson,Chaitanya Bandlamudi,Pedram Razavi,Gopa Iyer,Mark E. Robson,Zsofia K. Stadler,Nikolaus Schultz,José Baselga,David B. Solit,David M. Hyman,Michael F. Berger,Barry S. Taylor	2018	343
16	Genome sequencing of the extinct Eurasian wild aurochs, Bos primigenius, illuminates the phylogeography and evolution of cattle Stephen D. E. Park,David A. Magee,Paul McGettigan,Matthew D. Teasdale,Ceiridwen J. Edwards,Amanda J. Lohan,Alison Murphy,Martin Braud,Mark T.A. Donoghue,Yuan Liu,Andrew Chamberlain,Kévin Rue-Albrecht,Steven Schroeder,Charles Spillane,Shuaishuai Tai,Daniel G. Bradley,Tad S. Sonstegard,Brendan Loftus,David E. MacHugh	2015	115
17	Selective Methylation of Histone H3 Variant H3.1 Regulates Heterochromatin Replication Yannick Jacob,Elisa Bergamin,Mark T.A. Donoghue,V. Mongeon,Chantal LeBlanc,Philipp Voigt,Charles J. Underwood,J.S. Brunzelle,Scott D. Michaels,Danny Reinberg,Jean‐François Couture,Robert A. Martienssen	2014	145
18	ALCAM is indirectly modulated by miR-125b in MCF7 cells H. Begum Akman,S. Duygu Selçuklu,Mark T.A. Donoghue,Shiva Akhavantabasi,Ayşegül Sapmaz,Charles Spillane,M. Cengiz Yakıcıer,Ayşe Elif Erson-Bensan	2014	5
19	In Arabidopsis thaliana codon volatility scores reflect GC3 composition rather than selective pressure Mary J. O’Connell,Aisling Doyle,Thomas Juenger,Mark T.A. Donoghue,Channa Keshavaiah,Reetu Tuteja,Charles Spillane	2012	3
20	MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells S. Duygu Selçuklu,Mark T.A. Donoghue,Kristina Rehmet,Matheus de Souza Gomes,Antoine Fort,Prasad Kovvuru,Mohan Kumar Muniyappa,Michael J. Kerin,Anton J. Enright,Charles Spillane	2012	160

About Mark T.A. Donoghue

Mark T.A. Donoghue is a scholar working on Cancer Research, Oncology and Aging, having authored 58 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (17 papers), Plant nutrient uptake and metabolism (9 papers), Plant Molecular Biology Research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Sarcoma Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (5 papers), Testicular diseases and treatments (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Cancer Research (914 citations), Plant Science (1.1k citations) and Molecular Biology (1.8k citations). Mark T.A. Donoghue has collaborated with scholars based in United States, Ireland and Canada. Frequent co-authors include Charles Spillane, S. Duygu Selçuklu, Robert A. Martienssen, Barry S. Taylor, Filipe Borges, Frédéric Van Ex, Rui Gardner, Joseph P. Calarco, Frédéric Berger and Pauline E. Jullien.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact